association

Full identifier: http://purl.org/np/RAIztrMHG-yYosqB5N47FjRMlURxJBBMUwpw6xRf8onFY#association

Assigned to 1 class:

Minted in Nanopublication

 RAIztrMHG- comment approve/disapprove edit as derived nanopublication create new with same template

This is a local identifier that was minted when the nanopublication was created. http://purl.org/np/RAIztrMHG-...#association association https://w3id.org/biolink/vocab/has_population_context has_population_context This is a local identifier that was minted when the nanopublication was created. http://purl.org/np/RAIztrMHG-...#context context .
This is a local identifier that was minted when the nanopublication was created. http://purl.org/np/RAIztrMHG-...#context context http://www.w3.org/2000/01/rdf-schema#label label "Adolescents (15-17)" .
This is the identifier for this whole nanopublication. http://purl.org/np/RAIztrMHG-... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAhNHZw6Ur... RAhNHZw6Ur .
This is a local identifier minted within the nanopublication. http://purl.org/np/RAIztrMHG-...#sig sig http://purl.org/nanopub/x/hasSignatureTarget has as target This is the identifier for this whole nanopublication. http://purl.org/np/RAIztrMHG-... this nanopublication .
This is a local identifier minted within the nanopublication. http://purl.org/np/RAIztrMHG-...#sig sig http://purl.org/nanopub/x/hasAlgorithm has the algorithm (this is a literal) "RSA" .

Vincent Emonet, 16 Sep 2022, 11:50:48 UTC

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:50:48.517Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Similarly, De Cos Milas et al. [6] described their clinical experience with paliperidone in adolescents. They presented 3 males and 2 females, age between 15 and 17 years. Diagnoses were autism, borderline personality disorder, schizotypal personality disorder, personality disorder not otherwise specified, and schizophrenia. Prescribed dose was 3–9 mg/day, and actual mean time of treatment duration is 5.8 months. In 4 cases, paliperidone was initiated as a change from other antipsychotic. There were no adverse effects that required discontinuation and in all cases symptoms improved.
Vincent Emonet
2022-09-16T11:50:48.517Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:50:48.517Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:50:48.517Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:50:48.517Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:50:48.517Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:50:48.517Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:50:48.517Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:50:48.517Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:50:48.517Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)